Overview

JAMA Journal Articles Review

• Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation - Hakeem Yousef, MD
• Systemic Immunomodulatory Treatments for Atopic Dermatitis - Lauren Van Hove, MD
• Immune-Mediated and Psychiatric Comorbidities Among Patients Newly Diagnosed With Alopecia Areata - Allison Smith, MD
• Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis - Akhil Abraham, MD

Accreditation

HealthPartners is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

HealthPartners Office of Continuing Medical Education designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives

Regularly attending this series will allow participants to be able to:

• Apply best practices and current guidelines in treating dermatological conditions  
• Practice the art of reading an article and reviewing its merits
• Engage in discussion of how the article can lead to changes in medical practice